Stocks and Investing Stocks and Investing
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019
Mon, December 30, 2019
Fri, December 27, 2019
Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019
Fri, December 20, 2019
Thu, December 19, 2019

Keay Nakae Maintained (ALNY) at Strong Buy with Increased Target to $190 on, Dec 19th, 2019


Published on 2024-10-26 19:23:11 - WOPRAI
  Print publication without navigation


Keay Nakae of Chardan Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $150 to $190 on, Dec 19th, 2019.

Keay has made no other calls on ALNY in the last 4 months.



There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 1 agrees with Keay's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $96 on, Wednesday, September 4th, 2019


These are the ratings of the 5 analyists that currently disagree with Keay


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $176 on, Wednesday, December 18th, 2019
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Tuesday, December 17th, 2019
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $143 on, Monday, November 25th, 2019
  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $145 on, Tuesday, September 3rd, 2019